Liwen Ren

机构：Harbin Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing General Hospital of Nanjing Military Command, First Affiliated Hospital of Harbin Medical University, Nanjing University

发表论文 70 篇 · 总被引 2927 次 · h-index 27

代表论文

• CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis (2022 · Journal of Translational Medicine · 被引 115)
• Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis (2022 · Pharmacological Research · 被引 100)
• Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways (2022 · Acta Pharmaceutica Sinica B · 被引 69)
• GABAergic signaling as a potential therapeutic target in cancers (2023 · Biomedicine & Pharmacotherapy · 被引 65)
• Recent advances in epigenetic anticancer therapeutics and future perspectives (2023 · Frontiers in Genetics · 被引 35)
• S670, an amide derivative of 3-O-acetyl-11-keto-β-boswellic acid, induces ferroptosis in human glioblastoma cells by generating ROS and inhibiting STX17-mediated fusion of autophagosome and lysosome (2023 · Acta Pharmacologica Sinica · 被引 18)